Maternal and Perinatal Outcomes Associated With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta (B.1.617.2) Variant

Obstet Gynecol. 2021 Dec 1;138(6):842-844. doi: 10.1097/AOG.0000000000004607.

Authors

Angela R Seasely¹, Christina T Blanchard, Nitin Arora, Ashley N Battarbee, Brian M Casey, Jodie Dionne-Odom, Sixto M Leal Jr, Derek B Moates, Rachel G Sinkey, Jeff M Szychowski, Alan T Tita, Akila Subramaniam; CWRH COVID-19 Working Group

Affiliation

¹ Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, the Center for Women's Reproductive Health, the Division of Infectious Diseases, Department of Medicine, the Division of Neonatology, Department of Pediatrics, and the Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, Department of Pathology at the University of Alabama at Birmingham.

PMID: 34592747
DOI: 10.1097/AOG.0000000000004607

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

COVID-19 / virology*
Cohort Studies
Female
Humans
Infant, Newborn
Pregnancy
Pregnancy Complications, Infectious / virology*
Pregnancy Outcome
Retrospective Studies
SARS-CoV-2*

Supplementary concepts

SARS-CoV-2 variants